ArticleAntibodies (Basel, Switzerland)2025

Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer.

Isis Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.